The Federal Trade Commission cleared the way Thursday for Schering-Plough's $41.1 billion acquisition of Merck & Co., but required both companies to make significant divestures. Under the terms of the FTC's consent order, Merck must sell its interest in Merial Limited, an animal health joint venture with Sanofi-Aventis, and Schering-Plough must sell its assets related to drugs that treat nausea and vomiting in humans.
October 30, 2009 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
The Federal Trade Commission cleared the way Thursday for Schering-Plough‘s $41.1 billion acquisition of Merck & Co., but required both companies to make significant divestures.
Under the terms of the FTC’s consent order, Merck must sell its interest in Merial Limited, an animal health joint venture with Sanofi-Aventis, and Schering Plough must sell its assets related to drugs that treat nausea and vomiting in humans.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
